Literature DB >> 22484498

Synthesis, characterization, and anticancer activity of ruthenium-pyrazole complexes.

Solene David1, Richard S Perkins, Frank R Fronczek, Sahba Kasiri, Subhrangsu S Mandal, Radhey S Srivastava.   

Abstract

A series of new water soluble Ru(III) pyrazole complexes mer-[RuCl(3)(DMSO-S)(pyz)(2)] 1, mer-[RuCl(3)(DMSO-S)(DMSO-O)(pyz)] 2, mer-[RuCl(3)(bpy)(dmpyz)] 3, and mer-[RuCl(3)(DMSO-S)(dmpyz)(2)] 4 (pyz=pyrazole; dmpyz=3,5-dimethylpyrazole, bpy=2,2'-bipyridine) have been synthesized and characterized by use of a combination of spectroscopy (IR and UV-visible), X-ray diffraction, and cyclic voltammetry. The molecular X-ray structure of all reported compounds (1-4) revealed distorted octahedral coordination around ruthenium. The cytotoxicity assay on human breast cancer cells (MCF7) demonstrated that compounds 1 and 4 affect cell viability, whereas compounds 2 and 3 do not show appreciable activity. The IC(50) values for 1 and 4 lie within the range of 71-32μM in MCF7 cells.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22484498     DOI: 10.1016/j.jinorgbio.2012.02.022

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  3 in total

1.  Synthesis and cytotoxicity against tumor cells of pincer N-heterocyclic ligands and their transition metal complexes.

Authors:  Afaf Oulmidi; Smaail Radi; Abderrazak Idir; Abdelmajid Zyad; Imad Kabach; Mohamed Nhiri; Koen Robeyns; Aurelian Rotaru; Yann Garcia
Journal:  RSC Adv       Date:  2021-10-27       Impact factor: 4.036

Review 2.  Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors.

Authors:  Prakash Thangavel; Buddolla Viswanath; Sanghyo Kim
Journal:  Int J Nanomedicine       Date:  2017-04-04

3.  The Anticancer Activities of Some Nitrogen Donor Ligands Containing bis-Pyrazole, Bipyridine, and Phenanthroline Moiety Using Docking Methods.

Authors:  Adebayo A Adeniyi; Peter A Ajibade
Journal:  Bioinorg Chem Appl       Date:  2018-06-04       Impact factor: 7.778

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.